Semaglutide vs Tirzepatide — Which GLP-1 Wins for Weight Loss? (2026)

Semaglutide and tirzepatide are the two most-prescribed weight-loss medications in U.S. MedSpa weight-management programs in 2026. Both are weekly injectables. Both produce significant weight loss. But they don't work the same way — and the results, cost, and side-effect profiles differ in ways that matter when you're choosing a program.

How Semaglutide Works

Semaglutide (brand names: Wegovy for weight loss, Ozempic for type 2 diabetes) is a GLP-1 receptor agonist. It mimics the GLP-1 hormone your gut releases after eating — slowing stomach emptying, increasing satiety, and reducing food cravings. Most patients lose 10–15% of body weight over 12–18 months on a maintained dose.

How Tirzepatide Works

Tirzepatide (brand names: Zepbound for weight loss, Mounjaro for type 2 diabetes) is a dual GLP-1 / GIP receptor agonist. The added GIP activity amplifies the metabolic and appetite-suppression effects. In head-to-head clinical trials, patients on tirzepatide lost meaningfully more weight than patients on semaglutide — typically 15–22% of body weight over 12–18 months.

Side-by-Side Comparison

• Mechanism — Semaglutide: GLP-1 only. Tirzepatide: GLP-1 + GIP
• Average weight loss (72-week clinical data) — Semaglutide: ~15%. Tirzepatide: ~21%
• Dosing — Both: once-weekly subcutaneous injection
• Titration — Both: gradual dose increase to minimize side effects
• MedSpa program cost — Semaglutide: $250–$650/month. Tirzepatide: $400–$900/month
• Side effects (both) — nausea, constipation, fatigue, occasional GI upset; mostly during dose escalation

What Most MedSpa Programs Include

• Initial consultation and medical screening (BMI, labs, contraindications)
• Monthly medication supply (compounded or brand depending on program)
• Regular check-ins with a provider (often NP or MD)
• Dose titration plan
• Some programs include B12 / lipotropic injections, nutritional guidance, or InBody scans

Compounded vs Brand-Name

Many MedSpas offer compounded semaglutide and tirzepatide at significantly lower cost than the FDA-approved brand-name versions (Wegovy, Zepbound). Compounded versions are not FDA-approved — they're produced by licensed compounding pharmacies. Quality varies. If you're considering a compounded program, confirm the compounding pharmacy is accredited (look for 503A or 503B certification) and ask about their testing and sourcing.

Which One Should You Choose?

If maximum weight loss is your goal and budget allows, tirzepatide consistently outperforms semaglutide in clinical trials. If you've already had good results on semaglutide, want a lower monthly cost, or your insurance covers Wegovy/Ozempic, semaglutide remains a strong choice. Either way, the most important factor is staying on the medication long enough — both work best when continued for 12+ months alongside meaningful lifestyle changes.